You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 30 No. 4, April 1974 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Leukocyte Sensitivity to Brain Fractions in Neurological Diseases

Ellsworth C. Alvord, Jr., MD; Patricia C. Hsu, MS; Rosemarie Thron

Arch Neurol. 1974;30(4):296-299.


Abstract

Quantitative comparisons have been made of the degree of inhibition of migration of buffy coat leukocytes on exposure to various concentrations of several physicochemically separated fractions of brain. By contrast with leukocytes obtained from normal people, those from several patients with multiple sclerosis (MS) are inhibited on exposure to remarkably small concentrations of ultracentrifugally prepared synaptosomes. Stroke patients become comparably sensitized during the first week after the stroke, and some patients with brain tumors are also hypersensitive. Since it is unlikely that patients with MS can be tested before they acquire the disease, it will be very difficult to establish whether autosensitization can be primarily (etiologically) involved in MS. Whether autosensitization can be secondarily (pathogenetically) involved in MS still remains to be proved.



Author Affiliations

Seattle

From the Laboratory of Neuropathology, Department of Pathology, University of Washington, School of Medicine, Seattle.


Footnotes

Accepted for publication Oct 4, 1973.

Reprint requests to Division of Neuropathology, RJ-05, University of Washington, School of Medicine, Seattle 98195 (Dr. Alvord).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Blood Genomics in Human Stroke
Baird
Stroke 2007;38:694-698.
ABSTRACT | FULL TEXT  

The Forgotten Lymphocyte: Immunity and Stroke
Baird
Circulation 2006;113:2035-2036.
FULL TEXT  

Elevated pro-inflammatory CD4+CD28- lymphocytes and stroke recurrence and death
Nadareishvili et al.
Neurology 2004;63:1446-1451.
ABSTRACT | FULL TEXT  

Adoptive Transfer of Myelin Basic Protein-Tolerized Splenocytes to Naive Animals Reduces Infarct Size: A Role for Lymphocytes in Ischemic Brain Injury?
Becker et al.
Stroke 2003;34:1809-1815.
ABSTRACT | FULL TEXT  

Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia
Becker et al.
Proc. Natl. Acad. Sci. USA 1997;94:10873-10878.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1974 American Medical Association. All Rights Reserved.